Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Oxford Gene Technology grants microarray license to Applied Microarray Inc.


Oxford, July 4th, 2007 - Oxford Gene Technology (OGT) and Applied Microarrays Inc (AMI) are pleased to announce the completion of a licence agreement granting AMI access to OGT's 'Southern array patents', the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays.

Applied Microarrays Inc., who recently acquired Codelink technology from GE Healthcare, are now licensed to fabricate, market and distribute Codelink microarrays worldwide. In addition, this license grants OEM rights allowing AMI to manufacture custom microarrays for third parties under their own brand name. All microarrays fabricated by AMI include rights for their use within Service organisations.

Sue Sutton, Vice President Licensing North America, at OGT said: 'This license agreement is important in that it will ensure the continued supply of Codelink microarrays to the market and gives companies without their own microarray fabrication facility the opportunity to add microarrays to their product portfolio'.

Alastair Malcolm, President and CEO of AMI, added 'This agreement enables Applied Microarrays to support our customers in the life science research, clinical diagnostics, and drug development markets with a wide range of microarray products. We look forward to many new customer partnerships which will use our competencies in custom array co-development, and utilize our microarray factory's capacity to support high quality and affordable contract manufacturing.'

The licence will remain valid for the patents' lifetime. Financial details were not disclosed.

- ENDS -

For further information, please contact:

At Oxford Gene Technology:

Nicola Booton-Mander, Marketing Manager
Oxford Gene Technology
Begbroke Science Park,
Sandy Lane, Yarnton
Oxford OX5 1PF

T: +44 1865 856352
F: +44 1865 842116
E: licensing@ogt.co.uk
W: www.ogt.co.uk

Media Enquiries:
Annabel Entress, 0207 268 3002 / a.entress@northbankcommunications.com
Sarah Jeffery, 0207 268 3002 / s.jeffery@northbankcommunications.com

At Applied Microarrays Inc.

Randall Lockner, VP Business Development
7700 S. River Parkway
Tempe, AZ 85284
T: 480 775 6320
F: 800 927 9315
E: sales@appliedmicroarrays.com

Notes to editors
About Oxford Gene Technology

Founded in 1995 by the pioneer of Southern Blotting, Professor Sir Edwin Southern, OGT operates out of Begbroke Business Park near Oxford, with excellent access to a growing network of life science companies
OGT offers a comprehensive custom microarray consultancy service, from experimental design through all stages to data analysis and interpretation. It has a strong proven track record in providing custom microarray service in a range of applications, and recently announced the launch of its first microarray product, an Escherichia coli K12 ChIP on chip, the first ChIP microarray product to be launched as part of OGT's Prokaryotic Chip2 family

The key focus areas of OGT include:

1. Array-based application products and services for life science research and molecular diagnostics. OGT's flexible and cost-effective, customised DNA microarray service covers a range of applications, offering specialist support and assisting customers with every aspect of their research, from initial consultation and experimental design to probe selection, array design and fabrication through to data analysis and interpretation.
2. Development of innovative platform products for clinical research and diagnostics
3. Licensing. OGT operates an open licensing policy which has successfully provided access for a number of companies to OGT's fundamental intellectual property, particularly in the area of microarrays
4. Scientific collaborations to generate diagnostic biomarker intellectual property

For further information on OGT visit http://www.ogt.co.uk/

About Applied Microarrays Inc.
AMI is a privately held c


Publisher Contact Information:

Oxford Gene Technology (OGT)
+44 1865 856352
licensing@ogt.co.uk

Company profile of Oxford Gene Technology (OGT)
Past press releases of Oxford Gene Technology (OGT).

Data


27,746
Tech investments
From our Online Data Service
17,891
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.